These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26320526)

  • 21. [Clinical practice guidelines for diagnosis and treatment of osteoporosis].
    Hayashi Y
    Nihon Rinsho; 2003 Feb; 61(2):245-51. PubMed ID: 12638216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The new concept for the diagnosis of osteoporosis].
    Soen S
    Nihon Rinsho; 2015 Oct; 73(10):1645-8. PubMed ID: 26529925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The Diagnosis and Treatment of Osteoporosis].
    Kageyama G
    Rinsho Byori; 2015 May; 63(5):570-9. PubMed ID: 26524896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the FRAX and Garvan fracture risk calculators in older women.
    Bolland MJ; Siu AT; Mason BH; Horne AM; Ames RW; Grey AB; Gamble GD; Reid IR
    J Bone Miner Res; 2011 Feb; 26(2):420-7. PubMed ID: 20721930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Bone mineral measurements and guideline].
    Fukunaga M; Sone T
    Clin Calcium; 2008 Aug; 18(8):1089-95. PubMed ID: 18677045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic purpose and treatment guideline of osteoporosis].
    Ogawa S; Ouchi Y
    Clin Calcium; 2012 Jun; 22(6):885-9. PubMed ID: 22653029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skeletal diseases in Cushing's syndrome: osteoporosis versus arthropathy.
    Kaltsas G; Makras P
    Neuroendocrinology; 2010; 92 Suppl 1():60-4. PubMed ID: 20829620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of osteoporosis and vertebral fractures in patients presenting with moderate-to-severe chronic obstructive lung disease.
    Ogura-Tomomatsu H; Asano K; Tomomatsu K; Miyata J; Ohmori N; Kodama M; Ueda S; Takihara T; Tanaka K; Kamiishi N; Suzuki Y; Fukunaga K; Oguma T; Sayama K; Betsuyaku T
    COPD; 2012 Aug; 9(4):332-7. PubMed ID: 22489911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoporosis in men: update 2011.
    Orwig DL; Chiles N; Jones M; Hochberg MC
    Rheum Dis Clin North Am; 2011 Aug; 37(3):401-14, vi. PubMed ID: 22023899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinson's disease and osteoporosis.
    van den Bos F; Speelman AD; Samson M; Munneke M; Bloem BR; Verhaar HJ
    Age Ageing; 2013 Mar; 42(2):156-62. PubMed ID: 23132148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rates of non-vertebral osteoporotic fractures in rheumatoid arthritis and postfracture osteoporosis care in a period of evolving clinical practice guidelines.
    Roussy JP; Bessette L; Bernatsky S; Rahme E; Lachaine J
    Calcif Tissue Int; 2014 Jul; 95(1):8-18. PubMed ID: 24736884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.
    Bultink IE; Baden M; Lems WF
    Expert Opin Pharmacother; 2013 Feb; 14(2):185-97. PubMed ID: 23317448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of the patient with a high risk of fracture in clinical practice. Results from a survey of 174 Spanish Rheumatologists (OSTEOPAR project)].
    Casado E; Caamaño M; Sánchez-Bursón J; Salas E; Malouf J; Rentero ML; Herrero-Beaumont G
    Reumatol Clin; 2011; 7(5):305-13. PubMed ID: 21925446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Teriparatide treatment of severe osteoporosis reduces the risk of vertebral fractures compared with standard care in routine clinical practice.
    Oswald AJ; Berg J; Milne G; Ralston SH
    Calcif Tissue Int; 2014 Feb; 94(2):176-82. PubMed ID: 24026567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of pediatric osteoporosis.
    Bachrach LK
    Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):454-60. PubMed ID: 25232753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidemiology of bone and joint disease - the present and future - . Epidemiology of osteoporosis and osteoporotic fracture in Japan].
    Iki M
    Clin Calcium; 2014 May; 24(5):657-64. PubMed ID: 24769675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.
    Donaldson MG; Palermo L; Ensrud KE; Hochberg MC; Schousboe JT; Cummings SR
    J Bone Miner Res; 2012 Aug; 27(8):1804-10. PubMed ID: 22492479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment thresholds for osteoporosis and reimbursability criteria: perspectives associated with fracture risk-assessment tools.
    Adami S; Bertoldo F; Gatti D; Minisola G; Rossini M; Sinigaglia L; Varenna M
    Calcif Tissue Int; 2013 Sep; 93(3):195-200. PubMed ID: 23754490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management recommendations for osteoporosis in clinical guidelines.
    Wang M; Bolland M; Grey A
    Clin Endocrinol (Oxf); 2016 May; 84(5):687-92. PubMed ID: 26668071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.